Minimally Invasive Surgical Instruments Industry Overview

The global minimally invasive surgical instruments market size was estimated at USD 31.65 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2030.

Surgical robots have revolutionized the field of minimally invasive surgeries (MIS) and their acceptance by the surgeons is rising globally. The cost of MIS procedures is significantly less than in-patient and conventional open surgeries with equal outcomes resulting in a significant increase in value for the patient as well as insurance providers.

This trend is likely to continue in the coming years. Increasing number of new product launches and a growing number of product approvals by several market players for gaining a larger market share are anticipated to create robust growth opportunities for the industry. For instance, in December 2022, Abbott announced the launch of Navitor, an advanced transcatheter aortic valve implantation system. The device has wide application scope in the management of aortic stenosis.

Gather more insights about the market drivers, restrains and growth of the Minimally Invasive Surgical Instruments Market

In addition, the costs involved in MIS procedures are significantly less than in-patient and conventional open surgeries. Therefore, MIS procedures prove to be beneficial for patients as well as payers. The benefits of MIS in various areas of orthopedics have contributed to the growing demand for less traumatic alternatives with minimum tissue disruption of bones.

Noncommunicable Diseases (NCDs), often known as chronic diseases, affect more than 41 million individuals each year, accounting for approximately 74% of all deaths worldwide. According to the same source, nearly 15 million people aged 30 to 69 die worldwide each year as a result of NCDs. As a result of the high mortality rate due to NCDs, the need for therapeutic techniques is increasing. Minimally invasive techniques are gaining traction as they offer more benefits than regular procedures. As a result, the market under consideration is anticipated to grow over the forecast period.

Browse through Grand View Research's  Medical Devices Industry Research Reports.

• The global non-invasive brain trauma monitoring devices market size was valued at USD 14.0 billion in 2023 and is projected to grow at a CAGR of 8.6% from 2024 to 2030.
• The global colorectal surgery market size was valued at USD 20.52 billion in 2023 and is projected to grow at a CAGR of 8.6% from 2024 to 2030.

Minimally Invasive Surgical Instruments Market Segmentation

Grand View Research has segmented the global minimally invasive surgical instruments market on the basis of device, application, end-use, and region:

Minimally Invasive Surgical Instruments Device Outlook (Revenue, USD Million, 2018 - 2030)

• Handheld Instruments
• Inflation Devices
• Cutter Instruments
• Guiding Devices
• Electrosurgical Devices
• Auxiliary Devices
• Monitoring & Visualization Devices

Minimally Invasive Surgical Instruments Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiac
• Gastrointestinal
• Orthopedic
• Vascular
• Gynecological
• Urological
• Thoracic
• Cosmetic
• Dental
• Others

Minimally Invasive Surgical Instruments End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics
• Ambulatory Surgical Centers

Minimally Invasive Surgical Instruments Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

• Medtronic
• Siemens
• Healthineer AG
• Ethicon, Inc. (Johnson & Johnson)
• Depuy Synthes
• GE Healthcare
• Abbott Laboratories
• Intutive Surgical, Inc.
• Nuvasive, Inc.
• Zimmer Biomet

Key Minimally Invasive Surgical Instruments Company Insights

Most market players have strong collaborations with manufacturers and suppliers to ensure uninterrupted global supply. Many companies are involved in strategic partnerships and mergers & acquisitions as their global strategies. For instance, in February 2023, Encision Inc. signed a Proof of Concept Services Agreement with Vicarious Surgical Inc. The Vicarious surgical robot design plans to boost precision, control, and visualization of instruments in robotic-assisted minimally invasive surgery. Also, in November 2022, New View Surgical, Inc. announced the closure of USD 12.1M Series to fund the commercialization of VisionPort System.

Order a free sample PDF of the Minimally Invasive Surgical Instruments Market Intelligence Study, published by Grand View Research.